Finally, combining FGFR3 mutational status with methylation measurement of a set of DNA methylation markers (HS3ST2, SEPTIN9 and SLIT2) led to a sensitivity/specificity/NPV of 94.5/75.9/98.5%, respectively, for detection of a recurrent tumor [51]. Here, FGFR3 is linked to neoplasm.